AnaptysBio, Inc. (ANAB) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
AnaptysBio, Inc. (ANAB) reported a Q4 loss of $0.72 per share, which is better than the Zacks Consensus Estimate of a $1.61 loss. This is an improvement from the $1.59 loss per share a year ago.
February 28, 2025 | 1:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AnaptysBio reported a Q4 loss of $0.72 per share, better than the expected $1.61 loss, showing improvement from last year's $1.59 loss per share.
The better-than-expected earnings report is likely to positively impact ANAB's stock price in the short term. The improvement from last year's loss also suggests a positive trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100